Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Extended Monsoons Help Pep Up Sales In India; Anti-infectives Show Revival In August

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Heavy monsoon rains during the month of August helped the Indian pharmaceutical industry revive from its sagging July sales as the anti-infectives market showed signs of picking up momentum

You may also be interested in...

With Top 20 Companies Growing In Double Digits, India’s Pharma Market Zooms 21.5% In November

The Indian pharmaceutical market grew speedily at 21.5% during November, turning up a positive surprise for an industry already racing at an average 15% year-on-year growth for the last few months.

In India, June Was An Odd Month As Sales Disappointed But Future Looks Bright

MUMBAI - For the thousands of medical representatives in India chasing aggressive targets, June is a critical month as it marks the start of the monsoon season. Monsoons last four months as heavy rains lead to a surge in cases of infectious diseases, diarrhea, asthma and respiratory issues. Sales of medicines as such are remarkably higher in these months compared to the rest of the year. But this year, June has been an odd and rather disappointing month, with sales growing at just 12.6%, down almost 2% from May which showed a growth of 14.5%

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts